FHIR © HL7.org  |  Server Home  |  XIG Home  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

Resources - All Kinds, Realm US

18,284 resources

Type: Text:

By Version

By Authority

 

Start Prev Rows 10400 - 10600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuth
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.96MMR Deficient NCIactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.97MMR Proficient SNOMEDactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.98MMR Proficient LOINCactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1260.99MMR Proficient NCIactive2024-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1262.3ICD9 Codes for HIV Diagnosisactive2023-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.1Inpatient Pneumonia Diagnosisactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.11Chest Imaging for Pneumonia, HCPCSactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.12Chest Imaging for Pneumonia Grouping Definitionactive2024-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.18ICD9 Abnormal Finding on Chest Imagingactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.19ICD10 Abnormal Finding on Chest Imagingactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.2ICD9 Pneumonia Definitionactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.20SNOMEDCT Abnormal Finding on Chest Imagingactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.21Abnormal Finding on Chest Imagingactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.22SNOMEDCT Pneumonia Definitionactive2023-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.23CAP Concurrent Infectionsactive2024-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.24CAP Pneumonia Diagnosticactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.25Antibiotic Usage for CAP Diagnosisactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.27Legionella Presence by Urine Antigen or DNAactive2024-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.29Broad Spectrum Antibiotics for MDROactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.3ICD10 Pneumonia Definitionactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.32CPT Transplants, Stem Cell and Solidactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.33HCPCS Transplant, Stem Cell and Solidactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.34ICD10CM Transplant, Stem Cell and Solidactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.35ICD10PCS Transplant, Stem Cell and Solidactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.37SNOMEDCT Transplant, Stem Cell and Solidactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.38Transplant, Stem Cell and Solidactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.39Antibiotic Usage for CAP Durationactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.40CAP Sepsis Diagnosticactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.41CAP Respiratory Failure Diagnosticactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.42MRSA Organism or Substance in Lab Resultsactive2024-12hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.8Systemic Antimicrobialsactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1264.9Chest Imaging for Pneumonia, CPTactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.1Problem Typeactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.10Information Source for Medication Adherence HSLOCactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.11Information Source for Medication Adherenceactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.14Unknown and Asked but Unknown (DAR)active2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.15Yes or No SCTactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.16Answer Set with Yes No and Unknownsactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.17Common LOINC Lab Codesactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.18Radiology Procedures (LOINC)active2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.21Universal Common LOINC Lab Ordersactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.22Route of Administration of Therapeutic Agentsactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.23Encounter Typeactive2025-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.27Social History Type (LOINC)active2025-05hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.28Social History Typeactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.3Smoking status comprehensiveactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.4Smoking Status Type LOINCactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.5Smoking Status Pack Years SCTactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.6Smoking Status Typeactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.7Information Source for Medication Adherence HL7 Role Codeactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.8Information Source for Medication Adherence ParticpationFunctionactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1267.9Information Source for Medication Adherence SCTactive2024-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.1Malnutritionactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.10Fractureactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.11Transplant Diagnosesactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.13Transplant Diagnoses ICD10CMactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.14Transplant Diagnoses SNOMED CTactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.15Respiratory Proceduresactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.3Diabetesactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.4Diabetesactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.5Diabetesactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.6Immobilityactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.7Smoking statusactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.8Obesityactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1272.9Hormone Therapyactive2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1282.1Drug Intervention Not Indicated/Contraindicatedactive2024-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1282.10Endotracheal Intubationactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1282.2Procedure Not Indicated/Contraindicatedactive2024-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1282.9Mechanical Circulatory Assist Deviceactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1289.1RXNormSBD0305active2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1289.2RXNormSCD0305active2025-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113762.1.4.1290.4Sequential Organ Failure Assessment SOFAactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.10612Unknown Nullactive2019-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.19601x_ServiceEventPerformeractive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.1.11.20549Criticality Observationactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.15.2.5.1Initial Case Report Trigger Code Result Statusactive2024-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.15.2.5.12Therapeutic Response to Medicationactive2024-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.1.5.9.2Codes for MDRO and CDI Summary Data LTCFactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.1.5.9.3NHSNPrimaryResidentServiceTypeactive2020-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.1.5.9.4Codes for Denominators for Long Term Care Locations LTCFactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.1.5.9.5Codes for Prevention Process Measures LTCFactive2023-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.1.9.1NHSNReportNoEventsMDROLTCFactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.10Codes for Healthcare Personnel Influenza Vaccination (HP FLU) Summary Dataactive2019-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.11Codes for Hemovigilance (HV) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.12Codes for Intensive Care Unit (ICU) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.13Codes for Neonatal Intensive Care Unit (NICU) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.15Codes for Prevention Process and Outcome Measures (POM) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.16Codes for Specialty Care Area (SCA) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.17Codes for Vascular Access Type (Dialysis) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.18NHSNReportNoEventsICUactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.19NHSNReportNoEventsNICUactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.20NHSNReportNoEventsSCAactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.21NHSNReportNoEventsMDROactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.22NHSNReportNoEventsDialysisactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.24NHSNVascularSpecimenCollectionSiteactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.29NHSNSSIDetectionMethodactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.3NHSNLastLocationEncounterTypeCodeactive2020-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.30NHSNLOS/MENDischargeDispositionactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.31NHSNSSIDetectionMethodTypeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.32Codes for Outpatient Procedure Component Same Day Outcome Measures Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.33NHSNReportNoEventsOPCSameDayOutcomeMeasuresactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.34NHSNOPCProcedureCategoryCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.35NHSNReportNoEventsARactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.4NHSNDrugSusceptibilityTestMethodactive2020-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.40NHSN COVID19 Case Classificationactive2021-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.5NHSN Pathogen Reduced Apheresis Platelet Usageactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.50NHSNGenotypicTestInterpretationactive2024-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.6HealthcarePersonnelTypeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.7NHSNInfluenzaVaccinationSettingactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.8Codes for Antimicrobial Resistance Option (ARO) Summary Dataactive2020-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.10.20.5.9.9Codes for Antimicrobial Usage, Pharmacy (AUP) Summary Dataactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.12.1Personal And Legal Relationship Role Typeactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.21AgePQ_UCUMactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.32DIRDocumentTypeCodesactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.47ADL Result Typeactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.49Residence and Accommodation Typeactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.50Sensory Status Problem Typeactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.51Healthcare Agent Qualifieractive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.52Encounter SCTactive2024-10hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.56Referral Typesactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.62Related Document (append/replace)active2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.66Patient Referral Act moodCodeactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.68Note Typesactive2024-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.11.20.9.69.4Advance Healthcare Directive Categories LOINCactive2025-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.1NHSNEncounterTypeCodeactive2019-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.10NHSNASAClassCodeactive2019-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.11NHSNSpinalFusionLevelCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.12NHSNOccasionOfDetectionCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.13NHSNDrugSusceptibilityFindingCodeactive2020-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.15NHSNDrugSusceptibilityTestsCodeactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.16NHSNPathogenCodeactive2023-11hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.17NHSNProcedureCategoryCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.19NHSNHealthcareServiceLocationCodeactive2019-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.2NHSNSpinalFusionApproachCodeactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.20NHSNInfectionTypeCodeactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.3NHSNHipReplacementCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.4NHSNKneeReplacementCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.6NHSNInfectionRiskFactorsCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.7NHSNBloodStreamInfectionEvidenceTypeCodeactive2020-08hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.13.9NHSNWoundClassCodeactive2020-07hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.17.4077.2.1017Closed Head and Facial Traumaactive2020-09hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.17.4077.2.1018Closed Head and Facial Traumaactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.134Oral Factor Xa Inhibitor for VTE Prophylaxis or VTE Treatmentactive2022-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.136Perforation of Uterusactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.137Uterine Windowactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.138Uterine Ruptureactive2024-04hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.200Anticoagulant Therapyactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.201Antithrombotic Therapy Anticoagulantactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.202Atrial Fibrillation or Flutteractive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.203Atrial Ablationactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.204Carotid Interventionactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.205Direct Thrombin Inhibitoractive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.207Discharged to Health Care Facility for Hospice Careactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.209Discharged to Home for Hospice Careactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.211Injectable Factor Xa Inhibitor for VTE Prophylaxisactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.212Hemorrhagic Strokeactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.213INRactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.214Intermittent pneumatic compression devicesactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.215LDLcactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.218Unfractionated Heparinactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.219Low Molecular Weight Heparin for VTE Prophylaxisactive2023-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.222Intravenous routeactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.223Subcutaneous routeactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.226Thrombolytic tPA Therapyactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.230Venous foot pumpsactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.232Warfarinactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.234Hemorrhagic Strokeactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.235Hemorrhagic Strokeactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.238Carotid Interventionactive2025-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.239Carotid Interventionactive2019-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.242Atrial Ablationactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.243Atrial Ablationactive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.244Atrial Fibrillation or Flutteractive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.245Atrial Fibrillation or Flutteractive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.246Atrial Fibrillation or Flutteractive2025-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.247Ischemic Strokeactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.25Single Live Birthactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.251Ischemic Stroke Embolismactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.252Ischemic Stroke Embolismactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.255General Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.256Graduated compression stockingsactive2024-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.257Gynecological Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.258Hip Fracture Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.259Hip Replacement Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.26Single Live Born Newborn Born in Hospitalactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.260Intracranial Neurosurgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.261Knee Replacement Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.263Obstetrical or Pregnancy Related Conditionsactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.264Obstetrics VTEactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.27Dietary Intake Other than Human Milkactive2021-02hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.270Acute or Persistent Asthmaactive2022-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.271Acute or Persistent Asthmaactive2022-01hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.272Urological Surgeryactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.279Venous Thromboembolismactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.281Laboractive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.282Cesarean Birthactive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.286Conditions Possibly Justifying Elective Delivery Prior to 39 Weeks Gestationactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.288Medical Induction of Laboractive2022-03hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.292Emergency Department Visitactive2021-06hl7
us.nlm.vsacR4ValueSet/2.16.840.1.113883.3.117.1.7.1.294Decision to Admit to Hospital Inpatientactive2021-02hl7